Gomekli is part of the
Kinase Inhibitors class and treats
Neurofibromatosis.
Kinase inhibitors are used to treat cancers such as
leukemia,
breast cancer,
melanoma,
lung cancer, and
renal cancer. They are also used to prevent
organ transplant rejection. They work by stopping cancer cell growth and preventing the spread of the cells. Gomekli is only available as a brand name drug.
